UnknownNCT01660308
Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia
Studying Oncogenic osteomalacia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Taiwan University Hospital
- Principal Investigator
- Shyang-Rong Shih, PhDNational Taiwan University Hospital
- Enrollment
- 40 target
- Eligibility
- 20-85 years · All sexes
- Timeline
- 2011 – 2016
Study locations (1)
- National Taiwan University Hospital, Taipei, Taiwan, Taiwan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01660308 on ClinicalTrials.govOther trials for Oncogenic osteomalacia
Additional recruiting or active studies for the same condition.